Primary Malaria in London

Primary health care in London--changes since the Acheson report.

OBJECTIVE To examine changes in primary care in London in the 11 years since the Acheson report on primary health care in inner London. DESIGN Analysis of key data from the family health services authority performance indicators and from the Department of Health; study of trends since the time of the Acheson report; examination of the provision of primary care in 1990-1 and its relation to he...

Primary care in inner London: inadequate and exposed.

Malaria drug - resistance in Iran

Introduction: Malaria is a public health problem for approximately 2.4 billion people, 40% of the world’s population, particularly in the tropical and subtropical countries. Countries in Asia, and Latin America, the islands of the South, West, and central pacific ocean are all affected. Drug resistance is the greatest challenge in combating against malaria. Drug resistance in malaria is now w...

Epidemiology of Malaria in Kashan

ABSTRACT Every year in the city of Kashan various number of cases of malaria has been observed. Determination of the prevalence of the disease and the carriers in this area of the country can play a significant role in employing preventive measure as well as in managing logistic services. Through applying retrospective descriptive methods and based on the statistics reported from the Center o...

Potent in vivo anti-malaria activity of Goniothalamin against rodent malaria parasite infection in mice

Goniothalamin was evaluated for its anti-malaria activity in-vivo, using the 4-Day Suppressive Test (Peters & Robinson, 1975). The test were carried out against two strains of rodent malaria parasites, the sensitive strain P. berghei ANKA (MRA 311) strain and the resistant strain P. yoelii (MRA 312). An Initial screening was carried out using a single dose of 10 mg/kg body weight administered s...